Insulin-like growth factor II
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Insulin-like growth factor II
- DrugBank Accession Number
- DB14472
- Background
The insulin-like growth factor II is a well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. This factor presents effects related to growth regulation, insulin-like and mitogenic activities. To perform its biological activities, this growth factor can present some dependence to somatotropin. It is believed to be a major fetal growth factor in contrast to insulin-like growth factor I, which is a major growth factor in adults.
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- CG-IGF2
- Human insulin-like growth factor II
- Human oligopeptide-24
- IGF-2
- IGF-II
- Insulin-like growth factor 2
- Insulin-like growth factor II (human)
- Insulin-like growth factor-2
- Insulin-like growth factor-II
- Multiplication-stimulating activity III-2
- RH-oligopeptide-8
- RH-polypeptide-31
- SH-polypeptide-31
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image HUCORD HSCM-100 Ampoule Liquid 0.0000633 g/100mL Topical Hucord Co., Ltd. 2015-12-29 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image HUCORD HSCM-100 Ampoule Insulin-like growth factor II (0.0000633 g/100mL) Liquid Topical Hucord Co., Ltd. 2015-12-29 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 95067D43FQ
- CAS number
- 67763-97-7
References
- General References
- Not Available
- External Links
- 1728770
- Wikipedia
- Insulin-like_growth_factor_2
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Topical 0.0000633 g/100mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 22:30 / Updated at October 04, 2020 11:46